Gastric cancer: p-mTOR a more valuable prognostic marker than mTOR
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
- In gastric cancer (GC) phosphorylated mammalian target of rapamycin (p-mTOR) is a more valuable prognostic marker than mTOR.
Why this matters
- Novel prognostic biomarker for GC urgently needed.
- mTOR, p-mTOR, p70S6k, and p-p70S6K expression rates were 60.8%, 54...